+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Mitsubishi Tanabe Pharma Corp - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 41 Pages
  • February 2025
  • GlobalData
  • ID: 5125692
Mitsubishi Tanabe Pharma Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The analyst’s summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Mitsubishi Tanabe Pharma Corp (Mitsubishi Tanabe), a subsidiary of Mitsubishi Chemical Holdings Corp, identifies, develops, manufactures, procures, and commercializes ethical drugs and over-the-counter (OTC) pharmaceutical products. The company develops ethical drugs for autoimmune diseases, diabetes, kidney diseases, central nervous system (CNS) disorders, and others. It also develops vaccines for preventing various infectious diseases. Mitsubishi Tanabe also offers major products for skin conditions and digestive medicines. The company markets its products to wholesalers, hospitals, clinics, and drugstores. It has subsidiaries in Asia, Europe, and North America. Mitsubishi Tanabe is headquartered in Osaka, Japan.

Mitsubishi Tanabe Pharma Corp Key Recent Developments

  • Jan 10, 2025: Synaffix secures ADC deals with Boehringer and Mitsubishi Tanabe
  • Dec 12, 2024: Announcement of Organizational Changes and Personnel Changes of the Mitsubishi Group
  • May 09, 2024: Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions
  • May 09, 2024: The Global Health Innovative Technology Fund Provides Grant to Mitsubishi Tanabe Pharma and DNDi for Chagas Disease Drug Discover

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Mitsubishi Tanabe Pharma Corp - Key Facts
  • Mitsubishi Tanabe Pharma Corp - Key Employees
  • Mitsubishi Tanabe Pharma Corp - Major Products and Services
  • Mitsubishi Tanabe Pharma Corp - History
  • Mitsubishi Tanabe Pharma Corp - Company Statement
  • Mitsubishi Tanabe Pharma Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Mitsubishi Tanabe Pharma Corp - Business Description
  • R&D Overview
  • Mitsubishi Tanabe Pharma Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Mitsubishi Tanabe Pharma Corp - Strengths
  • Mitsubishi Tanabe Pharma Corp - Weaknesses
  • Mitsubishi Tanabe Pharma Corp - Opportunities
  • Mitsubishi Tanabe Pharma Corp - Threats
  • Mitsubishi Tanabe Pharma Corp - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
  • Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
  • Mitsubishi Tanabe Pharma Corp, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • Jan 10, 2025: Synaffix secures ADC deals with Boehringer and Mitsubishi Tanabe
  • Dec 12, 2024: Announcement of Organizational Changes and Personnel Changes of the Mitsubishi Group
  • May 09, 2024: Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions
  • May 09, 2024: The Global Health Innovative Technology Fund Provides Grant to Mitsubishi Tanabe Pharma and DNDi for Chagas Disease Drug Discover
  • Mar 04, 2024: Expiration of Marketing Alliance Agreement for TENELIA Tablets, TENELIA OD Tablets and CANAGLU Tablets
  • Feb 27, 2024: Announcement of Organizational Changes and Personnel Changes of the Mitsubishi Chemical Group
  • Jan 26, 2024: Mitsubishi Tanabe Pharma Contribute Funding To Global Health Innovative Technology Fund’s Third Phase -Targeting Treatments for Infectious Diseases That Burden the Developing World
Section 5 - Appendix
  • Methodology
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Mitsubishi Tanabe Pharma Corp, Key Facts
  • Mitsubishi Tanabe Pharma Corp, Key Employees
  • Mitsubishi Tanabe Pharma Corp, Major Products and Services
  • Mitsubishi Tanabe Pharma Corp, History
  • Mitsubishi Tanabe Pharma Corp, Other Locations
  • Mitsubishi Tanabe Pharma Corp, Subsidiaries
  • Mitsubishi Tanabe Pharma Corp, Joint Venture
  • Mitsubishi Tanabe Pharma Corp, Key Competitors
  • Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
  • Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
  • Mitsubishi Tanabe Pharma Corp, Recent Deals Summary
List of Figures
  • Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
  • Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Daiichi Sankyo Co Ltd
  • Tsumura & Co
  • Astellas Pharma Inc
  • Taisho Pharmaceutical Holdings Co Ltd
  • Chugai Pharmaceutical Co Ltd